Zeria Pharmaceutical Co Ltd
TSE:4559
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Zeria Pharmaceutical Co Ltd
Zeria Pharmaceutical Co Ltd
Intangible Assets
Zeria Pharmaceutical Co Ltd
Intangible Assets Peer Comparison
4502
4568
4578
4519
4503
Competitive Intangible Assets Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Zeria Pharmaceutical Co Ltd
TSE:4559
|
Intangible Assets
¥9.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
25%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Intangible Assets
¥4.3T
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
14%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Intangible Assets
¥168.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Intangible Assets
¥511.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
15%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Intangible Assets
¥19.6B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
8%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Intangible Assets
¥1.5T
|
CAGR 3-Years
31%
|
CAGR 5-Years
28%
|
CAGR 10-Years
18%
|
See Also
What is Zeria Pharmaceutical Co Ltd's Intangible Assets?
Intangible Assets
9.4B
JPY
Based on the financial report for Mar 31, 2024, Zeria Pharmaceutical Co Ltd's Intangible Assets amounts to 9.4B JPY.
What is Zeria Pharmaceutical Co Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
25%
Over the last year, the Intangible Assets growth was 11%. The average annual Intangible Assets growth rates for Zeria Pharmaceutical Co Ltd have been 7% over the past three years , 6% over the past five years , and 25% over the past ten years .
You don't have any saved screeners yet
